Sleep Disorder Clinical Trial
Official title:
The Effects of Exercise Training in Community-dwelling Elderly With Sleep Disturbances With Follow-up: Body Composition and Energy Metabolism
This study will explore the long-term effects of exercise training on body composition, cardiorespiratory fitness, and energy metabolism in the community-dwelling elderly with sleep disturbances
Status | Active, not recruiting |
Enrollment | 260 |
Est. completion date | January 2020 |
Est. primary completion date | January 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: 1. Community dwelling sedentary men and women who were 65 years or older Exclusion Criteria: 1. History of Diagnostic and Statistical Manual Diploma in Social Medicine, 4th. Edition (DSM-IV) criteria for any major psychiatric disorder, including mania or alcohol or substance abuse 2. History of cognitive or other neurological disorders 3. Other sleep disorders by history or documented on screening polysomnography (apnea index >10, periodic leg movement arousal index >15, or rapid eye movement (REM) behavior disorder 4. Unstable or serious medical conditions or cardiopulmonary disease that contraindicate exercise 5. BMI > 35 kg/m2 6. Individual with a life expectancy of no more than 1 years or final stage of cancer |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Taiwan | National Taiwan University | Taipei |
Lead Sponsor | Collaborator |
---|---|
National Taiwan University Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body fat percentage | Body fat percentage in percentage. | Up to 1 year (the first year) | No |
Secondary | Body fat mass | Body fat mass in kilograms. | Up to 1 year (the first year) | No |
Secondary | Body fat free mass | Body fat free mass in kilograms. | Up to 1 year (the first year) | No |
Secondary | Body mass index | BMI in kg/m^2. | Up to 1 year (the first year) | No |
Secondary | Rest metabolic rate | Rest metabolic rate in percentage. | Up to 1 year (the first year) | No |
Secondary | Impedance | Impedance in ohm. | Up to 1 year (the first year) | No |
Secondary | Resistance | Resistance in ohm. | Up to 1 year (the first year) | No |
Secondary | Electroencephalography(EEG) | Electroencephalography was assessed during sleep. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Electrooculography(EOG) | Electrooculography was assessed during sleep. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Electromyography(EMG) | Electromyography was assessed during sleep. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Electrocardiography(ECG) | Electrocardiography was assessed during sleep. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Pittsburgh sleep quality index | Up to 1 year (the first year) | No | |
Secondary | Dual energy X-ray absorptiometry | Pretest and after 24 weeks intervention (the second year) | No | |
Secondary | Triglyceride | Triglyceride in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Total cholesterol | Total cholesterol in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Insulin | Insulin in uIU/mL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Fasting glucose | Fasting glucose in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Glycated hemoglobin(HbA1C) | HbA1C in percentage. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | High-density lipoprotein | High-density lipoprotein in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Low-density lipoprotein | Low-density lipoprotein in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | C-reactive protein | C-reactive protein in mg/dL. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Heart rate variability | It is measured by the variation in the beat-to-beat interval. Methods used to detect beats is electrocardiography. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Maximum oxygen consumption | Use treadmill exercise testing. | Pretest and after 24 weeks intervention (the second year) | No |
Secondary | Three factor eating questionnaire | Up to 1 year (the first year) | No | |
Secondary | Taiwan Geriatric Depression Scale | Up to 1 year (the first year) | No | |
Secondary | Groningen Activity Restriction Scale | Up to 1 year (the first year) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Recruiting |
NCT04786314 -
The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome
|
N/A | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT03326765 -
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT03903263 -
Sleep Disturbances in Dermatology Patients
|
||
Not yet recruiting |
NCT05950932 -
Effects of Melissa Extract on Sleep Characteristics
|
Phase 4 | |
Not yet recruiting |
NCT06012513 -
Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
|
||
Completed |
NCT01463839 -
Sleep Disorder and Oral Habits in Children
|
N/A | |
Completed |
NCT00940589 -
Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor
|
Phase 2 | |
Recruiting |
NCT06093633 -
A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
|
||
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Completed |
NCT05511818 -
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
|
N/A | |
Active, not recruiting |
NCT04291014 -
Light Therapy for PD - Dose Selection
|
N/A | |
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Completed |
NCT06008470 -
Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection
|
||
Recruiting |
NCT06129942 -
Light Therapy in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04318067 -
Melatonin in ADHD and Sleep Problems
|
Phase 4 | |
Completed |
NCT03532269 -
Validation of the Sleep Assessment Algorithm in the Medical Application Nightly
|
N/A | |
Completed |
NCT03857802 -
Efficiency of a Nursing Intervention in Sleep Hygiene
|
N/A |